Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.070
0.00 (0.00%)
Jun 26, 2026, 11:09 AM EDT - Market open
Compass Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
39
Market Cap
372.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 850.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 227.18M |
| Vanda Pharmaceuticals | 217.78M |
| Enanta Pharmaceuticals | 69.21M |
| Fennec Pharmaceuticals | 51.00M |
| Verastem | 49.59M |
| X4 Pharmaceuticals | 9.01M |
CMPX News
- 17 days ago - Compass Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire
- 5 weeks ago - Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 5 weeks ago - Compass Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 5 weeks ago - Compass Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire
- 7 weeks ago - Compass Therapeutics reports Q1 EPS (10c), consensus (10c) - TheFly